Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1435-1441, doi:10.1016/j.jacc.2008.07.044
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molyneux, S. L.
Right arrow Articles by Richards, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Molyneux, S. L.
Right arrow Articles by Richards, A. M.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: HEART FAILURE

Coenzyme Q10

An Independent Predictor of Mortality in Chronic Heart Failure

Sarah L. Molyneux, PhD*, Christopher M. Florkowski, MD*,*, Peter M. George, MB, BS*, Anna P. Pilbrow, PhD{dagger}, Christopher M. Frampton, PhD{dagger}, Michael Lever, PhD* and A. Mark Richards, MD, PhD{dagger}

* Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand
{dagger} The Christchurch Cardioendocrine Research Group, Department of Medicine, University of Otago (Christchurch), Christchurch, New Zealand

Manuscript received March 3, 2008; revised manuscript received July 14, 2008, accepted July 21, 2008.

* Reprint requests and correspondence: Dr. Christopher M. Florkowski, Clinical Biochemistry Unit, Canterbury Health Laboratories, P.O. Box 151, Christchurch 8140, New Zealand (Email: chris.florkowski{at}cdhb.govt.nz).

Objectives: The aim of this study was to investigate the relationship between plasma coenzyme Q10 (CoQ10) and survival in patients with chronic heart failure (CHF).

Background: Patients with CHF have low plasma concentrations of CoQ10, an essential cofactor for mitochondrial electron transport and myocardial energy supply. Additionally, low plasma total cholesterol (TC) concentrations have been associated with higher mortality in heart failure. Plasma CoQ10 is closely associated with low-density lipoprotein cholesterol (LDL-C), which might contribute to this association. Therefore we tested the hypothesis that plasma CoQ10 is a predictor of total mortality in CHF and could explain this association.

Methods: Plasma samples from 236 patients admitted to the hospital with CHF, with a median (range) duration of follow-up of 2.69 (0.12 to 5.75) years, were assayed for LDL-C, TC, and total CoQ10.

Results: Median age at admission was 77 years. Median (range) CoQ10 concentration was 0.68 (0.18 to 1.75) µmol/l. The optimal CoQ10 concentration for prediction of mortality (established with receiver-operator characteristic [ROC] curves) was 0.73 µmol/l. Multivariable analysis allowing for effects of standard predictors of survival—including age at admission, gender, previous myocardial infarction, N-terminal peptide of B-type natriuretic peptide, and estimated glomerular filtration rate (modification of diet in renal disease)—indicated CoQ10 was an independent predictor of survival, whether dichotomized at the ROC curve cut-point (hazard ratio [HR]: 2.0; 95% confidence interval [CI]: 1.2 to 3.3) or the median (HR: 1.6; 95% CI: 1.0 to 2.6).

Conclusions: Plasma CoQ10 concentration was an independent predictor of mortality in this cohort. The CoQ10 deficiency might be detrimental to the long-term prognosis of CHF, and there is a rationale for controlled intervention studies with CoQ10.

Key Words: chronic heart failure • coenzyme Q10 • mortality

Abbreviations and Acronyms
  CHF = chronic heart failure
  CI = confidence interval
  CoQ10 = coenzyme Q10
  GFR = glomerular filtration rate
  LDL-C = low-density lipoprotein cholesterol
  MDRD = modification of diet in renal disease
  MI = myocardial infarction
  NT-proBNP = N-terminal peptide of B-type natriuretic peptide
  NYHA = New York Heart Association
  ROC = receiver-operator characteristic
  TC = total cholesterol


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
V. Soukoulis, J. B. Dihu, M. Sole, S. D. Anker, J. Cleland, G. C. Fonarow, M. Metra, E. Pasini, T. Strzelczyk, H. Taegtmeyer, et al.
Micronutrient deficiencies an unmet need in heart failure.
J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1660 - 1673.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement